Phase 3 Genetic Clinical Trials
16 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–16 of 16 trials
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Symptomatic Genetic Dilated Cardiomyopathy
Kardigan, Inc.332 enrolled43 locationsNCT07210723
Recruiting
Phase 3
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Female Pattern Baldnessandrogenetic alopecia
Industrial Farmacéutica Cantabria, S.A.520 enrolled13 locationsNCT05888922
Recruiting
Phase 3
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Nervous system diseasePeripheral nervous system diseaseAmyloidosis+17 more
Intellia Therapeutics60 enrolled14 locationsNCT06672237
Recruiting
Phase 3
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563
Recruiting
Phase 3
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
androgenetic alopecia
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.294 enrolled1 locationNCT07080931
Recruiting
Phase 3
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
B-ALLMRD-positiveAllogenetic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital70 enrolled1 locationNCT07441291
Recruiting
Phase 3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Hypothalamic ObesityMultiple Pituitary Hormone Deficiency Genetic FormSepto-Optic Dysplasia+3 more
Rhythm Pharmaceuticals, Inc.39 enrolled11 locationsNCT06760546
Not Yet Recruiting
Phase 3Phase 4
Topical Dutasteride on Male pattern hairloss.
androgenetic alopecia
Eric Song - Reskin Medical20 enrolled1 locationACTRN12626000082303
Recruiting
Phase 3
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
Skin DiseasesEpidermolysis BullosaConnective Tissue Disease+7 more
Chiesi Farmaceutici S.p.A.6 enrolled6 locationsNCT06917690
Recruiting
Phase 3
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
androgenetic alopecia
EMS190 enrolled1 locationNCT04594018
Recruiting
Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Androgenetic alopecia (AGA)Hair LossAGA+2 more
Veradermics, Inc.552 enrolled71 locationsNCT07146022
Recruiting
Phase 3
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
Male Pattern Baldnessandrogenetic alopecia
Samson Clinical Operations Pty Ltd132 enrolled3 locationsNCT06924632
Recruiting
Phase 2Phase 3
Herbal Ointment in Treating Atopic Dermatitis Topically
atopic dermatitis (eczema)Atopic DermatitisAtopic Dermatitis (AD)+4 more
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting
Phase 3
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
Preimplantation Genetic TestingGrowth HormoneAge, Parental
ShangHai Ji Ai Genetics & IVF Institute400 enrolled1 locationNCT05447208
Terminated
Phase 3
Genetic Risk Information Disclosure study.
Genetic mutations predisposing to breast, ovarian or colorectal cancer and methods of disclosing that information to relatives.
The Cancer Council Victoria40 enrolled1 locationACTRN12607000316404